US Dialysis Market

U.S. Dialysis Market Size

The U.S. dialysis market was estimated at USD 29.7 billion in 2024. The market is expected to grow from USD 30.9 billion in 2025 to USD 52.2 billion in 2034, growing at a CAGR of 6% from 2025 to 2034, according to the latest report published by Global Market Insights Inc. This high growth is attributed to several factors, including rising prevalence of kidney disorders in the country, shortage of donor kidneys, favorable reimbursement policies, and surging investments in research and development for the development of technologically advanced products.

When the kidneys lose their ability to function effectively, dialysis becomes a critical life-sustaining therapy that filters waste products and excess fluids from the blood. The demand for dialysis services is expected to grow steadily, driven primarily by the rising prevalence of diabetes and related kidney complications in the country. Key players shaping the industry include DaVita, Fresenius, Vantive (Baxter), B. Braun, and Mozarc Medical, along with several other regional and specialized providers. Within this space, the home dialysis segment is gaining significant traction, as it not only lowers the risk of hospital-acquired infections but also offers patients a more convenient and cost-effective alternative to in-center treatments.

The U.S. dialysis market is being driven by a combination of demographic, clinical, and technological factors. Rising prevalence of end-stage renal disease (ESRD) is a major factor creating a need for dialysis treatments. For instance, around 0.8 million U.S. citizens are suffering from ESRD. In addition, as per the National ESRD Census Data published in March 2025, over 0.5 million patients were being treated for dialysis in the country. The patients with ESRD are expected to witness growth owing to conditions such as an aging population, a rise in patients with hypertension, and others.

Moreover, the shortage of donor kidneys makes dialysis a long-term necessity for a large number of patients. According to data from the United Network for Organ Sharing (UNOS), a non-profit organization, nearly 90,000 individuals in the U.S. are currently on the waiting list for a kidney transplant. This substantial gap between demand and availability of donor organs drives the reliance on regular dialysis sessions, thereby fueling the growth of the industry.

Dialysis is an artificial process that removes waste products, excess salts, and fluids from the blood when the kidneys are no longer able to function adequately. The treatment is broadly categorized into two types such as hemodialysis and peritoneal dialysis. Patients with chronic kidney disease often require ongoing dialysis to support daily living and maintain essential bodily functions.

U.S. Dialysis Market Trends

• Increased adoption of home dialysis, favorable reimbursement policies, and technological advancements are key trends positively shaping the U.S. dialysis market.
  
• The market is witnessing a notable shift toward home-based therapies, as patients seek more convenient treatment options supported by policy incentives and technological innovation. For instance, according to the United States Renal Data System (USRDS), the share of new patients opting for home dialysis increased to 13.4% in 2021 from 7.5% in 2011.
  
• Healthcare providers are increasingly focusing on value-based care models that enable better kidney disease management and more comprehensive treatment. Digital health tools, including remote monitoring systems and AI-powered diagnostics, support the delivery of personalized care plans.
  
• Patients are also experiencing improved treatment outcomes and comfort with the introduction of biocompatible dialysis solutions and portable dialysis machines, which help reduce peritoneal membrane damage during peritoneal dialysis. These innovations are driving the adoption of home-based therapies.
  
• Additionally, Medicare’s comprehensive coverage significantly reduces out-of-pocket expenses, making dialysis more accessible and financially sustainable for patients. Such supportive reimbursement policies are expected to further accelerate market growth over the forecast period.
  

U.S. Dialysis Market Analysis

In 2021, the U.S. dialysis market was valued at USD 28.1 billion, rising slightly to USD 28.2 billion in 2022 and further to USD 28.8 billion in 2023. Growing awareness about kidney diseases, increasing focus on early diagnosis and timely therapeutic intervention, and the rise in the number of dialysis centers across the country are anticipated to drive industry growth.

Based on type, the U.S. dialysis market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment accounted for a dominant 86.5% share in 2024. It remains the standard treatment for patients with ESRD, particularly for the patients who are not the candidates for home-based therapies. The segment is expected to exceed USD 45.8 billion by 2034, growing at a CAGR of 6.2% during the forecast period.

• More people in the U.S. need hemodialysis treatment as the number of patients suffering from chronic kidney disease (CKD) and end-stage renal disease (ESRD) are witnessing a notable rise in the country. For instance, according to the data reported by the Centers for Disease Control and Prevention (CDC), more than 1 in 7 U.S. adults are suffering from CKD. Thus, such a high target population is expected to spur the demand for hemodialysis treatment over the forecast period.
  
• The demand for hemodialysis is rising in line with the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the U.S. For instance, according to the CDC, more than 1 in 7 U.S. adults are affected by CKD.
  
• Most patients receive treatment at hospitals and dialysis centers, which provide structured care and accessibility.
  
• Growing awareness has led to more patients getting diagnosed and treated, while supportive healthcare policies have improved access to dialysis services.
  
• Due to their complex medical needs, many patients prefer or require in-center care, ensuring steady demand in both urban and rural healthcare facilities.
  
• The peritoneal dialysis segment was valued at USD 4 billion in 2024. Unlike hemodialysis, peritoneal dialysis can be performed at home, allowing patients greater flexibility and control over their treatment. This at-home option improves overall well-being and convenience, making it an increasingly attractive alternative for suitable patients.
  

Based on end use, the U.S. dialysis market is segmented into in-center dialysis and home dialysis. The in-center dialysis segment accounted for the highest market share of 69.8% in 2024, as the majority of the dialysis patients in the country are suffering hemodialysis, and they need facility-based medical care.

• Facility based dialysis is widely available at many dialysis centers across the U.S. These centers have all the necessary medical equipment and experienced healthcare professionals to provide care, making it easier and more reliable for most patients, particularly those who need regular medical monitoring.
  
• In addition, many patients find in-center dialysis appealing because healthcare professionals handle their treatment schedule, which means less worry about managing care on their own. Further, people who don't feel confident or are able to do dialysis at home, getting treatment at a center offers a safer and more convenient way to receive care, thereby contributing to segmental growth.
  
• Moreover, the growing demand for the peritoneal dialysis segment is fueling the home-based treatment option in the country. The home dialysis segment is anticipated to witness robust growth with a CAGR of 6.7% over the analysis period.
  

South Atlantic zone dominated the U.S. dialysis market with the market share of 25% in 2024.

• The South Atlantic zone is facing growing healthcare challenges due to its expanding elderly population in states such as Florida, Virginia, Maryland, Georgia, and North Carolina, among others. Florida, in particular, is a key contributor, as it has one of the country’s highest proportions of elderly residents. Since older adults are more susceptible to chronic kidney disease (CKD) and end-stage renal disease (ESRD), the rising elderly population is driving demand for dialysis services.
  
• In recent years, the region has also experienced steady population growth due to domestic relocation, driven by factors such as a favorable climate and affordable living costs. This influx is expanding the patient pool, particularly among individuals with chronic kidney conditions. For instance, in March 2022, U.S. Renal Care, a leading service provider, announced the opening of four new dialysis facilities in Fort Myers, Florida. Such continuous expansion and upgrading of healthcare facilities are expected to further support regional market growth.
  

Pacific Central dialysis market accounted for USD 5.8 billion in 2024.

• The region is experiencing a rising demand for home-based dialysis solutions, driven by factors such as an aging population, a patient-centric approach to care, and improved access to universal healthcare systems. For instance, states like California are actively promoting home-based treatments to reduce the strain on public healthcare systems and provider resources.
  
• Additionally, government programs such as Medicare and Medicaid play a critical role in supporting dialysis services. For patients with ESRD, Medicare covers a significant portion of dialysis-related expenses. This reimbursement framework not only sustains service providers but also enables patients to access treatment options that align with their preferences.
  
• Furthermore, healthcare providers are enhancing chronic disease management efforts, particularly in underserved and rural communities. These initiatives are contributing to the wider adoption of home dialysis as a preferred treatment option, improving accessibility and patient outcomes across the region.
  

The Northeast dialysis market is anticipated to witness notable growth over the analysis timeframe.

• Healthcare providers are expanding their home dialysis services to address the increasing prevalence of ESRD patients in the region. Health systems across the area are offering more peritoneal dialysis and home hemodialysis options, giving patients greater flexibility while driving market growth.
  
• Several states in the region have also introduced supportive measures to make dialysis treatments more accessible through patient-centric healthcare policies in collaboration with providers. For example, in January 2022, NYU Langone Hospital in Long Island, NY, became the first hospital in the U.S. to provide home-based dialysis treatment for ESRD patients. This shift from hospital-based care to home-based treatment marks a key advancement for managing chronic conditions.
  
• Furthermore, the expansion of Medicaid coverage and the establishment of state-funded programs for low-income patients have improved access to dialysis services, thereby supporting regional market growth.
  

U.S. Dialysis Market Share

Leading industry players such as DaVita, Fresenius, and Vantive (Baxter) hold around 70% of the market share in the consolidated U.S. dialysis market. These companies maintain their leading position by combining strong product and service lines, business collaborations with healthcare providers, legal clearances, and consistent product innovation.

The market has many national and regional players actively competing for market share. Major companies are introducing advanced products and standardized services to help expand the market. Regional providers are working with an aim to improve their industry presence by expanding their services.

Additionally, such a competitive environment encourages innovation, leading to better patient care and more efficient operations. Companies are forming strategic partnerships, pursuing acquisitions, and investing in new technologies to build stronger market positions.

Further, substantial investment by industry players in research and development, partnerships with healthcare providers such as dialysis centers and hospitals, and a focus on bettering the home-based therapy portfolio are expected to support the market growth over the analysis period.

U.S. Dialysis Market Companies

Few of the prominent players operating in the U.S. dialysis industry include:

• Key players
  • angiodynamics
  • Asahi KASEI
  • B. Braun
  • Becton, Dickinson and Company
  • DaVita
  • Fresenius
  • Mozarc Medical
  • Teleflex
  • TERUMO
  • U.S. RENAL CARE
  • Vantive (Baxter)
• Emerging players
  • JMS
  • NIKKISO
  • NIPRO
  • Northwest Kidney Centers
  • POLYMED
  • Rogosin Institute
  • SATELLITE HEALTHCARE
  • TORAY
  • UTAH MEDICAL PRODUCTS INC.
    
• DaVita

DaVita leads the U.S. dialysis market with a share of around 38% in 2024 due to robust service portfolio and wide reach of the company throughout the country. DaVita emphasizes home dialysis, digital health, and value-based care. The company is investing in AI-driven early detection and predictive analytics to support its shift toward preventive, personalized kidney care provider. It is going through a transition from being a dialysis-centric company to a holistic kidney care provider.

• Fresenius

Fresenius is working with an aim to lead in value-based care, expand high-volume hemodiafiltration (HVHDF), and integrate AI across operations. It also has a keen focus on improving its vertical integration that supports company's leading position in both dialysis services and technology.

• B. Braun

B. Braun is expanding its presence through mobile dialysis services and ambulatory care models. It targets underserved and rural populations with cost-effective, flexible dialysis delivery. The company also emphasizes partnerships and government collaborations to scale access and improve outcomes in home and peritoneal dialysis.

• Mozarc Medical (Medtronic)

Medtronic is leveraging its medtech expertise to develop advanced peritoneal dialysis solutions, including portable and automated systems. It focuses on improving patient mobility, treatment adherence, and integration with telehealth platforms. Strategic R&D investments aim to enhance home dialysis adoption and clinical outcomes in the country.

U.S. Dialysis Industry News:

• In June 2025, Fresenius Medical Care received FDA 510 (k) clearance for its new hemodiafiltration-capable 5008X CARE system. The company plans to commercialize and launch the system in the U.S. in 2026. The clearance is provided for the updated version with additional features.
  
• In August 2024, Baxter International Inc. announced that they have signed an agreement with global investment firm Carlyle to divest their Kidney Care segment at a valuation of USD 3.8 Billion. This development is part of the Baxter's ongoing business transformation with a focus on operational efficiency and strategic clarity.
  
• In April 2023, Medtronic plc and DaVita Inc. announced the launch of Mozarc Medical, an independent company with a vision to reshape kidney care and drive patient-centered technology solutions in the industry. The company is co-owned by Medtronic and DaVita, with equal equity stakes.
  

The U.S. dialysis market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Hemodialysis
  • Equipment
    • Dialysis machines
    • Water treatment systems
  • Consumables
    • Dialyzers
    • Catheters
    • Access products
    • Concentrates
    • Other consumables
  • Services
    • Chronic dialysis
    • Acute dialysis
• Peritoneal dialysis
  • Equipment/Cyclers
  • Consumables
    • Peritoneal dialysis solution/Dialysate
      • Dextrose
      • Icodextrin
      • Amino Acid
    • Catheters
    • Access products
    • Other consumables
  • Services
    • Chronic dialysis
    • Acute dialysis

Market, By End Use

• In-center dialysis
• Home dialysis

The above information is provided for the following zones and states:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Central
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming